Keyphrases
2-Deoxy-d-glucose (2-DG)
60%
Apoptosis
20%
Cancer Cell Growth
40%
Cell Apoptosis
20%
Cell Autophagy
20%
Cell Cycle Arrest
20%
Crystal Violet Staining
20%
Current Therapies
20%
Flow Cytometry
20%
Genetic Changes
20%
Genetic Studies
20%
Glycolytic Enzymes
100%
Growth in Vitro
20%
Hexokinase
100%
Human Lung
40%
Human Lung Cancer Cell Line
20%
Immunoblotting
20%
Knock
40%
Knockdown
20%
KRAS mutation
60%
Lentivirus Infections
40%
Loss Function
20%
Lung Cancer Cell Lines
40%
Lung Cancer Cells
40%
Lung Tumor
100%
Mouse Lung
60%
Mutation Mutation
20%
New Targets
20%
Non-small Cell Lung Cancer (NSCLC)
60%
Pharmacological Studies
20%
Promising Treatment
20%
Short Hairpin RNA (shRNA)
40%
Targeted Treatment
20%
TP53 Deletion
20%
TP53 mutation
40%
Treatment Strategy
20%
Tumor Growth
100%
Western Blotting
20%
Xenograft Model
20%
Medicine and Dentistry
Autophagy
20%
Cancer Growth
40%
Cell Cycle Arrest
20%
Cell Cycle Checkpoint
20%
Cell Line
20%
Crystal Violet
20%
Flow Cytometry
20%
Gene Mutation
20%
Glycolytic Enzyme
100%
Hexokinase
100%
Immunoblotting
20%
In Vitro
20%
Lentivirus Infection
40%
Lung Cancer
40%
Lung Cancer Cell Line
60%
Lung Tumor
100%
Non-Small Cell Lung Cancer
60%
Programmed Cell Death
40%
Protein P53
100%
Short Hairpin RNA
40%
Tumor Progression
100%
Western Blotting
20%
Xenograft
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
40%
Crystal Violet
20%
Flow Cytometry
20%
Glycolytic Enzyme
100%
Hexokinase
100%
Lentivirus Infection
40%
Lung Cancer
100%
Lung Tumor
100%
Protein P53
100%
Short Hairpin RNA
40%
Tumor Growth
100%
Western Blot
40%